Close Menu

NEW YORK (GenomeWeb) – Personalized Wellness firm Arivale has suspended its direct-to-consumer business, stating on its website that the genetic, microbiome, and other lab tests involved in its coaching and monitoring service remain too costly for its business model to succeed at this time.

The timing is abrupt, considering that the company was anticipating a new study describing results in 2,500 participants, which it said has now been accepted for publication in Scientific Reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.